www.encognitive.com Over the last five years, the federal Food and Drug Administration (FDA) sent prescription drug companies 170 enforcement letters criticizing "false" or "misleading" advertising that omitted or minimized risks, promoted unproven uses, and made other deceptive claims to both doctors and consumers. Those letters addressed the marketing of 150 ...